THYROCAREThyrocare Technologies Limited
Healthcare · Diagnostics & Research · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on THYROCARE — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 24.3% YoY
- • Profit growth: 31.8% YoY
- • ROE: 27.8%
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • 3-month vs NIFTY: +6.3% relative
Bull case
- • Revenue growth: 24.3% YoY
- • Profit growth: 31.8% YoY
- • ROE: 27.8%
- • Price vs SMA200: above
Bear case
- • RSI: 39
- • MACD: bearish
- • 1-month return: -9.3%
- • 1-month vs NIFTY: -5.2% relative
Key risks
- • RSI: 39
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹18.91). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.